| Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors (NCT00743379) | Threshold Pharmaceuticals | 2008-08-01 |
| A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer (NCT00683475) | Eli Lilly and Company | 2008-08-01 |
| Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer (NCT00869739) | East Carolina University | 2008-08-01 |
| Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer (NCT00736645) | Roswell Park Cancer Institute | 2008-08-01 |
| Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer (NCT00736164) | Roswell Park Cancer Institute | 2008-08-01 |
| C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer (NCT00804245) | Wake Forest University Health Sciences | 2008-08-01 |
| Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer (NCT00726596) | Rutgers, The State University of New Jersey | 2008-08-01 |
| Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer (NCT00714753) | Mayo Clinic | 2008-08-01 |
| Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older (NCT00741039) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Psychosocial Adjustment After Radiation Therapy in Patients With Cancer (NCT00905086) | Case Comprehensive Cancer Center | 2008-08-01 |
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) (NCT00753415) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton (NCT00748046) | Bayer | 2008-08-01 |
| Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients (NCT00815750) | H. Lee Moffitt Cancer Center and Research Institute | 2008-08-01 |
| Testing the Helpfulness of 2 Decision Aids for Prostate Cancer (NCT00432601) | VA Office of Research and Development | 2008-08-01 |
| Health-Related Quality of Life in Gay Men With Localized Prostate Cancer (NCT00828633) | Baylor College of Medicine | 2008-08-01 |
| Robotic Seed Implantation for Prostate Cancer Brachytherapy (NCT01341288) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-07-29 |
| Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 (NCT00897351) | ECOG-ACRIN Cancer Research Group | 2008-07-10 |
| Herbal Therapy for Treatment of Recurrent Prostate Cancer (NCT00669656) | University of Southern California | 2008-07-06 |
| CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer (NCT00702923) | University of Wisconsin, Madison | 2008-07-01 |
| Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer (NCT00715104) | Dendreon | 2008-07-01 |
| Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer (NCT01013129) | Portland VA Medical Center | 2008-07-01 |
| A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT) (NCT00853164) | Washington University School of Medicine | 2008-07-01 |
| A Phase I/II Study of HE3235 in Patients With Prostate Cancer (NCT00716794) | Harbor Therapeutics | 2008-07-01 |
| Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer (NCT00738673) | Ferring Pharmaceuticals | 2008-07-01 |
| The AIM Study: Assessing the Impact of Margin Reduction (NCT00754000) | Varian, a Siemens Healthineers Company | 2008-07-01 |
| Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer (NCT00771017) | Eastern Cooperative Oncology Group | 2008-07-01 |
| Study to Monitor the Effects of Androgen Suppression Treatment on the Heart (NCT01230905) | Ottawa Heart Institute Research Corporation | 2008-07-01 |
| Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer (NCT01530295) | Hanjong Ahn | 2008-07-01 |
| A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer (NCT00644488) | Bristol-Myers Squibb | 2008-07-01 |
| Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer (NCT00651326) | NCIC Clinical Trials Group | 2008-06-02 |
| Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy (NCT00868868) | Groupe de recherche en Urologie de la Mauricie | 2008-06-01 |
| Implant Radiation Therapy or Surgery in Treating Patients With Prostate Cancer (NCT01098331) | University of Southampton | 2008-06-01 |
| Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy (NCT00692874) | AstraZeneca | 2008-06-01 |
| Androcur Effects on Quality of Life (NCT00908674) | Bayer | 2008-06-01 |
| Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer (NCT00658697) | Dana-Farber Cancer Institute | 2008-06-01 |
| Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer (NCT00694291) | Fox Chase Cancer Center | 2008-06-01 |
| Fiducial Localization and Individualized Radiotherapy -Prostate Cancer (NCT00789607) | University Health Network, Toronto | 2008-06-01 |
| Salvage Prostatectomy After Radiotherapy (NCT00791115) | University Health Network, Toronto | 2008-06-01 |
| Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer (NCT00728663) | Swiss Cancer Institute | 2008-06-01 |
| Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy (NCT00686036) | Genzyme, a Sanofi Company | 2008-05-01 |
| Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients (NCT00630799) | GP-Pharm | 2008-05-01 |
| Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents (NCT00712829) | Molecular Insight Pharmaceuticals, Inc. | 2008-05-01 |
| Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance (NCT00744549) | University Health Network, Toronto | 2008-05-01 |
| Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00703638) | Masonic Cancer Center, University of Minnesota | 2008-05-01 |
| Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer (NCT00769431) | Baylor College of Medicine | 2008-05-01 |
| Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients (NCT00714376) | CHU de Quebec-Universite Laval | 2008-05-01 |
| Efavirenz in Treating Patients With Metastatic Prostate Cancer (NCT00964002) | Institut Bergonié | 2008-05-01 |
| Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases (NCT00685646) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2008-05-01 |
| Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer (NCT00670046) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-05-01 |
| Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer (NCT00678015) | University of California, San Francisco | 2008-05-01 |
| Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer (NCT00667069) | UNICANCER | 2008-04-07 |
| Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer (NCT00664456) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2008-04-01 |
| Development of a Clinical Trial Specific Question Prompt List (NCT00662324) | Memorial Sloan Kettering Cancer Center | 2008-04-01 |
| Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer (NCT00551525) | Radiation Therapy Oncology Group | 2008-04-01 |
| The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients (NCT00859768) | Netherlands Open University | 2008-04-01 |
| Proton Therapy for Low and Intermediate Risk Prostate Cancer (NCT00693238) | University of Florida | 2008-04-01 |
| Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer (NCT00657982) | Sheba Medical Center | 2008-04-01 |
| The Effect of Endurance Training in Patients With Prostate Cancer (NCT01584960) | Inge Holm | 2008-04-01 |
| Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning (NCT00664196) | Roger Williams Medical Center | 2008-04-01 |
| Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy (NCT00528866) | Radiation Therapy Oncology Group | 2008-04-01 |
| SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer (NCT00773318) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2008-04-01 |
| Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer (NCT00667862) | Novartis Pharmaceuticals | 2008-03-18 |
| Predictive Genetic Risk Assessment Trial (NCT00782366) | Mayo Clinic | 2008-03-01 |
| A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer (NCT00642018) | Eli Lilly and Company | 2008-03-01 |
| Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy (NCT00807820) | University of California, San Francisco | 2008-03-01 |
| A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer (NCT00625430) | Biotech Equity Partners Pty Ltd | 2008-03-01 |
| Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04) (NCT00636558) | Viralytics | 2008-02-29 |
| Satraplatin and Prednisone to Treat Prostate Cancer (NCT00634647) | National Cancer Institute (NCI) | 2008-02-19 |
| Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer (NCT00638378) | Incyte Corporation | 2008-02-01 |
| Spectro-IRM and Evaluation Response to Prostatic Radiotherapy (NCT01412853) | Centre Georges Francois Leclerc | 2008-02-01 |
| Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02) (NCT01191931) | Advanced Medical Diagnostics s.a. | 2008-02-01 |
| Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer (NCT00577356) | Benaroya Research Institute | 2008-02-01 |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer (NCT00631527) | M.D. Anderson Cancer Center | 2008-02-01 |
| RAD001 and Bicalutamide for Androgen Independent Prostate Cancer (NCT00630344) | Dana-Farber Cancer Institute | 2008-02-01 |
| Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer (NCT01813097) | Chinese PLA General Hospital | 2008-02-01 |
| Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer (NCT00659438) | Genzyme, a Sanofi Company | 2008-02-01 |
| A Study of Leuprolide to Treat Prostate Cancer (NCT00626431) | Abbott | 2008-02-01 |
| Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients (NCT00654186) | Oncology Specialists, S.C. | 2008-02-01 |
| Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer (NCT00567580) | Radiation Therapy Oncology Group | 2008-02-01 |
| Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00758173) | Cancer Research UK | 2008-02-01 |
| Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer (NCT00731848) | Roll International Corporation | 2008-02-01 |
| A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer (NCT00663832) | Novartis Pharmaceuticals | 2008-02-01 |
| Genetic Investigation of Solid Tumors Cohort (NCT01005225) | Scripps Translational Science Institute | 2008-02-01 |
| Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease (NCT00558272) | AstraZeneca | 2008-02-01 |
| A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer (NCT00617669) | AstraZeneca | 2008-01-01 |
| The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer (NCT01089881) | National Taiwan University Hospital | 2008-01-01 |
| A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors (NCT02225262) | Community Cancer Center, Normal, Illinois | 2008-01-01 |
| A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (NCT00626548) | AstraZeneca | 2008-01-01 |
| Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy (NCT01009736) | Ohio State University Comprehensive Cancer Center | 2008-01-01 |
| Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants (NCT00898274) | Case Comprehensive Cancer Center | 2008-01-01 |
| [18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases (NCT00670527) | Odense University Hospital | 2008-01-01 |
| Observation or Radical Treatment in Patients With Prostate Cancer (NCT00499174) | NCIC Clinical Trials Group | 2007-12-06 |
| Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada (NCT00537849) | SonaCare Medical | 2007-12-01 |
| Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not (NCT00688532) | AstraZeneca | 2007-12-01 |
| Statin Therapy Versus Placebo Prior to Prostatectomy (NCT00572468) | VA Office of Research and Development | 2007-12-01 |
| Testosterone in Castration-Resistant Prostate Cancer (NCT00577980) | M.D. Anderson Cancer Center | 2007-12-01 |
| Active Control of Prostatic Cancer With Criteria of Latence (NCT00921258) | Clinique Mutualiste Chirurgicale de la Loire | 2007-12-01 |
| Randomized Trial of Suicide Gene Therapy and Prostate Cancer (NCT00583492) | Henry Ford Health System | 2007-12-01 |
| Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer (NCT00732043) | Roll International Corporation | 2007-12-01 |
| Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer (NCT00520546) | Dr. Markus Hartenbach | 2007-12-01 |